DA-8010 + paroxetine

**DA-8010 + paroxetine** is a combination of two orally administered small molecules. **DA-8010** is a novel selective muscarinic M3 receptor antagonist under development primarily for the treatment of overactive bladder, while **paroxetine** is a selective serotonin reuptake inhibitor (SSRI) widely approved and marketed for the treatment of major depressive disorder, various anxiety disorders, and other psychiatric and neurological conditions. Paroxetine acts by inhibiting the reuptake of serotonin into presynaptic neurons, thereby increasing synaptic serotonin activity. When used in combination, these drugs may be investigated for potential drug-drug interactions, pharmacodynamic or pharmacokinetic effects, or for specific therapeutic indications where both agents provide benefit, but compounding interactions and adverse effects must be carefully monitored.

Other names

paroxetine